The short version
20 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Periogard Alcohol Free
Chlorhexidine Gluconate · CHLORHEXIDINE GLUCONATE 1.2 mg/mL · Rinse · Buccal · Atlantic Biologicals Corp.
NDC 17856-0272-01 · 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 10 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00116-2001-16) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.0241per unit
middle half $0.0168–$0.0396 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0241
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for chlorhexidine gluconate (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA203212
- TE code
- AT
- Approval date
- Jan 28, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Chlorhexidine Gluconate (Rinse)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Atlantic Biologicals Corp. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Major Pharmaceuticals | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Aug 13, 2026 | Sep 3, 2026 |
| Xttrium Laboratories, Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Atlantic Biologicals Corps. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Benco Dental | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Darby Dental Supply, LLC | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Den-mat Holdings, Llc | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Dentsply LLC. Professional Division Trading as "DENTSPLY Professional" | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Lyne Laboratories, Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| McKesson | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medline Industries, LP | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals,Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Solventum US LLC | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| VistaPharm, LLC | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Colgate Oral Pharmaceuticals, Inc. | CHLORHEXIDINE GLUCONATE 1.2 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Periogard Alcohol Free — NDC 17856-0272-01," retrieved September 3, 2026, https://drugdashboards.com/drug/17856027201.
Free to cite with attribution — see how the data is put together.